Tenax Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TENX Nasdaq 8731 http://www.tenaxthera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tenax Therapeutics Inc

Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - May 31st, 2023 12:54 pm
TENX: Prioritizing Levosimendan - May 22nd, 2023 10:44 am
10 Stocks Targeted By Short Sellers Recently - Apr 21st, 2023 7:59 pm
Tenax Therapeutics Prioritizes Development Of TNX-103 For Heart Failure - Apr 12th, 2023 6:50 pm
Tenax Therapeutics Provides 2023 Business Update - Apr 12th, 2023 12:45 pm
TENX: Patents Guide the Way - Apr 5th, 2023 9:49 am
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Mar 22nd, 2023 12:45 pm
Analysts Are Optimistic We'll See A Profit From Tenax Therapeutics, Inc. (NASDAQ:TENX) - Feb 17th, 2023 12:05 pm
TENX: New Funding Puts Wind in the Sails - Feb 15th, 2023 1:05 pm
Triangle pharma raising millions amid uncertain future - Feb 7th, 2023 5:10 pm
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering - Feb 3rd, 2023 1:19 pm
Why Tenax Therapeutics Shares Are Gaining Today? - Feb 2nd, 2023 3:43 pm
Tenax Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF) - Feb 1st, 2023 9:31 pm
Tenax Therapeutics Announces Reverse Stock Split - Jan 4th, 2023 1:00 pm
TENX: Agility Required to Unlock Considerable Upside - Nov 3rd, 2022 11:16 am
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Oct 10th, 2022 12:30 pm
Tenax Therapeutics Stock Jumps On Strategic Alternative Review - Sep 15th, 2022 1:29 pm
Tenax Therapeutics Announces the Evaluation of Strategic Alternatives - Sep 15th, 2022 12:30 pm
Loss-Making Tenax Therapeutics, Inc. (NASDAQ:TENX) Expected To Breakeven In The Medium-Term - Aug 28th, 2022 1:23 pm
TENX: The Pressure’s On: Awaiting Phase 3 Start - Aug 23rd, 2022 9:58 am